Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event

NCT ID: NCT02877615

Last Updated: 2020-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

585 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-19

Study Completion Date

2019-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the efficacy and safety of S 44819 in enhancing functional recovery after an ischemic stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Stroke Recovery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

S 44819 150 mg twice a day

Group Type EXPERIMENTAL

S 44819 150 mg twice a day

Intervention Type DRUG

One sachet of S 44819 150 mg and one sachet of placebo twice a day

S 44819 300 mg twice a day

Group Type EXPERIMENTAL

S 44819 300 mg twice a day

Intervention Type DRUG

Two sachets of S 44819 150 mg twice a day

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Two sachets of placebo twice a day

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

S 44819 150 mg twice a day

One sachet of S 44819 150 mg and one sachet of placebo twice a day

Intervention Type DRUG

S 44819 300 mg twice a day

Two sachets of S 44819 150 mg twice a day

Intervention Type DRUG

Placebo

Two sachets of placebo twice a day

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged between 18 and 85 years (both inclusive)
* Acute ischemic stroke that occured between 72 hours (3 days) and 192 hours (8 days) (both inclusive) before inclusion

Exclusion Criteria

* Any non-selection criteria, which could have occurred after the selection visit
* Positive urinary or blood pregnancy test (for female patients of child bearing potential)
* Any clinically significant findings from the local laboratory test likely to interfere with the ability to participate in the study and / or with the study outcome
* Severe renal impairment detected in the local laboratory test
* Severe hepatic impairment or liver enzymes abnormalities found in the local laboratory test
* Stroke due to cerebral venous thrombosis
* Brain MRI showing a severe microangiopathy
* Brain imaging showing an acute haemorrhagic stroke or a symptomatic haemorrhagic transformation of the brain infarct
* Qualifying ischemic cerebral event older than 192 hours at inclusion
* Any clinically relevant abnormalities detected during the examinations likely to interfere with study procedures or study outcome,
* Repeated prolongation of ECG QTcF
* Patient or authorised representative refusing to attend study visits or to take part in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ADIR, a Servier Group company

INDUSTRY

Sponsor Role collaborator

Institut de Recherches Internationales Servier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Adelaide Hospital Department of Neurology

Adelaide, , Australia

Site Status

Sunshine Coast Hospital

Birtinya, , Australia

Site Status

Monash Medical Centre Department of Neurology

Clayton, , Australia

Site Status

Lyell McEwin Hospital Neurology Department

Elizabeth Vale, , Australia

Site Status

Gosford Hospital Neurosciences Department

Gosford, , Australia

Site Status

Austin Health Neurology Department

Heidelberg, , Australia

Site Status

Royal Brisbane & Women's Hospital Department of Neurology

Herston, , Australia

Site Status

Alfred Health

Melbourne, , Australia

Site Status

Royal Melbourne Hospital Department of Neurology

Parkville, , Australia

Site Status

Gold Coast University Hospital

Southport, , Australia

Site Status

AZ Sint-Lucas Neurologie

Bruges, , Belgium

Site Status

AZ. St. Jan

Bruges, , Belgium

Site Status

Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Jessa Ziekenhuis Dienst Neurologie

Hasselt, , Belgium

Site Status

UZ Leuven Campus Gasthuisberg

Leuven, , Belgium

Site Status

Les Cliniques Saint-Joseph

Liège, , Belgium

Site Status

Sint Andries Ziekenhuis Dienst Neurologie

Tielt, , Belgium

Site Status

Hospital das Clinicas da Faculdade de Medicina de Botucatu

Botucatu, , Brazil

Site Status

Clínica Neurológica e Neurocirúrgica de Joinville

Joinville, , Brazil

Site Status

Hospital Carlos Fernando Malzone Departamento de Neurologia

Matão, , Brazil

Site Status

IMV Pesquisa Neurológica Setor de Pesquisa Clinica

Porto Alegre, , Brazil

Site Status

Hospital Sao Lucas da Pontificia Universidade Catolica RS Setor de Pesquisa Clínica

Porto Alegre, , Brazil

Site Status

Hospital das Clinicas da Fac. de Med. de Ribeirao Preto Unidade de Emergencia - Centro de Estudo

Ribeirão Preto, , Brazil

Site Status

Hospital das Clinicas da Fac. de med. de Ribeirao Preto Unidade de Emergiancia

Ribeirão Preto, , Brazil

Site Status

Hospital Quinta D'or Departamento de Neurologia

Rio de Janeiro, , Brazil

Site Status

Irmandade Santa Casa de Misericordia de Sao Paulo Ambulatório de Neurologia

São Paulo, , Brazil

Site Status

UNIFESP - Universidade Federal de Sao Paulo Centro de Pesquisa em Neurologia

São Paulo, , Brazil

Site Status

University of Alberta

Edmonton, , Canada

Site Status

Charles LeMoyne Hospital-CISSS de la Monteregie-Centre

Greenfield Park, , Canada

Site Status

Montreal General Hospital

Montreal, , Canada

Site Status

Saint John Regional Hospital

Saint John, , Canada

Site Status

Fakultni nemocnice Brno Neurologicka klinika

Brno, , Czechia

Site Status

Fakultni nemocnice u sv. Anny Neurologicka klinika

Brno, , Czechia

Site Status

Nemocnice Jihlava

Jihlava, , Czechia

Site Status

Vseobecna fakultni nemocnice II. interni klinika VFN a 1. LF UK

Prague, , Czechia

Site Status

CHU Bdx-Hôpital Pellegrin-Tripode Service de Neurologie

Bordeaux, , France

Site Status

Hôpital Sud-Francilien Unité Neurovasculaire

Corbeil-Essonnes, , France

Site Status

CHU Henri Mondor Service de Neurologie

Créteil, , France

Site Status

CHU de Bicêtre Service de neurologie

Le Kremlin-Bicêtre, , France

Site Status

CHRU-Hôpital Roger Salengro Service de Neurologie

Lille, , France

Site Status

CHU-Hôpital Gui de Chaulliac Unité de Neuropshysiologie Clinique

Montpellier, , France

Site Status

Hôpital Lariboisière, Fernand-Vidal Service de Neurologie

Paris, , France

Site Status

Hôpital Sainte-Anne Service de Neurologie

Paris, , France

Site Status

CHU-Hôpital de la Milétrie Service de Neurologie

Poitiers, , France

Site Status

Klinikum Altenburger Land GmbH Neurologische Klinik

Altenburg, , Germany

Site Status

Neurologische Klinik GmbH, Bad Neustadt

Bad Neustadt an der Saale, , Germany

Site Status

Vivantes Klinikum Neukölln Klinik für Neurologie mit Stroke Unit

Berlin, , Germany

Site Status

Universitätsklinikum Erlangen Neurologische Klinik

Erlangen, , Germany

Site Status

Universitaetsklinikum Essen Neurologische Universitätsklinik Essen

Essen, , Germany

Site Status

Universitätsmedizin der Johannes Gutenberg-Universität Klinik und Poliklinik für

Mainz, , Germany

Site Status

Johannes Wesling Klinik Minden Klinik für Neurologie

Minden, , Germany

Site Status

Kreisklinikum Siegen Klinik fuer Neurologie

Siegen, , Germany

Site Status

Universitätsklinik der Eberhard-Karls Universtiät Tübingen Hertie-Institut für Klinische Hirnforschung

Tübingen, , Germany

Site Status

Universitätsklinikum Ulm Neurologische Klinik (RKU)

Ulm, , Germany

Site Status

Semmelweis Egyetem Neurologiai Klinika

Budapest, , Hungary

Site Status

Bajcsy-Zsilinszky Korhaz es Rendelointezet Neurologiai Osztaly

Budapest, , Hungary

Site Status

Szent Janos Korhaz Neurologiai osztaly

Budapest, , Hungary

Site Status

Honved Korhaz Stroke reszleg

Budapest, , Hungary

Site Status

Orszagos Idegsebeszeti Tudomanyos Intezet

Budapest, , Hungary

Site Status

Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly

Győr, , Hungary

Site Status

Somogy Megyei Kaposi Mor Oktato Korhaz Neurologiai Osztaly

Kaposvár, , Hungary

Site Status

Flor Ferenc Korhaz Neurologia

Kistarcsa, , Hungary

Site Status

B-A-Z Megyei Korhaz es Egyetemi Oktato Korhaz Stroke, Er- es Neurologiai, Toxikologiai Osztaly

Miskolc, , Hungary

Site Status

Kanizsai Dorottya Korhaz Neurologiai Osztaly

Nagykanizsa, , Hungary

Site Status

Josa Andras Oktatokorhaz Neurologiai Osztaly

Nyíregyháza, , Hungary

Site Status

Pecsi Tudomanyegyetem Klinikai Kozpont Neurologiai Klinika

Pécs, , Hungary

Site Status

Soproni Erzsebet Oktato Korhaz Neurologiai Osztaly

Sopron, , Hungary

Site Status

Szegedi Tudomanyegyetem Szent-Gyorgy Albert Klinikai Kozpont

Szeged, , Hungary

Site Status

Vito FAZZI U.O. semplice Stroke Unit

Lecce, , Italy

Site Status

Ospedale San Giuseppe UOC di Neurologia e Stroke Unit

Milan, , Italy

Site Status

Ospedale San Raffaele

Milan, , Italy

Site Status

Ospedale Sacro Cuore Don Calabria Negrar NEUROLOGY DEPT

Negrar, , Italy

Site Status

Istituto Neurologico mediterraneo NEUROMED Dipartimento di Medicina Riabilitativa e Specialistica Repar

Pozzilli, , Italy

Site Status

Policlinico Umberto I Emergency Department Stroke Unit

Rome, , Italy

Site Status

Zuyderland Medisch Centrum Afdeling Neurologie

Heerlen, , Netherlands

Site Status

UMC St Radboud Afdeling Neurologie

Nijmegen, , Netherlands

Site Status

Canisius Wilhelmina Ziekenhuis Afdeling Neurologie

Nijmegen, , Netherlands

Site Status

Erasmus MC Afdeling Neurologie

Rotterdam, , Netherlands

Site Status

Isala Klinieken Afdeling Neurologie

Zwolle, , Netherlands

Site Status

Samodzielny Publiczny Wojewodzki Szpital Specjalistyczny Oddzial Neurologiczny i Oddzial Udarowy

Chełm, , Poland

Site Status

M. Kopernika Provincial Specialist Hospital Dpt of Neurology

Gdansk, , Poland

Site Status

Szpital Specjalistyczny sw. Lukasza Oddzial Neurologii i Oddzial Udarowy

Gmina Końskie, , Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny nr7 SUM w Katowicach Oddzial Neurologii z Pododdzialem Udarowym

Katowice, , Poland

Site Status

Miejskie Centrum Medyczne Jonscher Szpital Dr K. Jonschera

Lodz, , Poland

Site Status

Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie Oddzial Neurologii

Lublin, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny SPZOZ nr 3 w Rybniku

Rybnik, , Poland

Site Status

Szpital Specjalistyczny Ducha Swietego w Sandomierzu Oddzial Neurologii

Sandomierz, , Poland

Site Status

Instytut Psychiatrii i Neurologii II Klinika Neurologiczna

Warsaw, , Poland

Site Status

Inje University Busan Paik Hospital

Busan, , South Korea

Site Status

Dong-A University Medical Center Department of Neurology

Busan, , South Korea

Site Status

Kyungpook National University Hospital Department of Neurology

Daegu, , South Korea

Site Status

Chonnam National University Hospital Department of Neurology

Gwangju, , South Korea

Site Status

Seoul National University Bundang Hospital Department of Orthopaedic

Seongnam, , South Korea

Site Status

Kyung Hee University Hospital

Seoul, , South Korea

Site Status

ASAN Medical Center Department of Neurology

Seoul, , South Korea

Site Status

H. General de Albacete Servicio de Neurología

Albacete, , Spain

Site Status

H. Germans Trias I Pujol Servicio de Neurología

Badalona, , Spain

Site Status

H. del Mar Neurología

Barcelona, , Spain

Site Status

H. Valle de Hebrón Servicio de Neurología

Barcelona, , Spain

Site Status

H. Clinic de Barcelona Comprehensive Stroke Center

Barcelona, , Spain

Site Status

Hospital Universitari de Bellvitge Servicio de Neurología-Unidad de Ictus-Planta 9

Barcelona, , Spain

Site Status

H. Universitario de Donosti Servicio de Neurología

Donostia / San Sebastian, , Spain

Site Status

H. Josep Trueta Servicio de Neurología

Girona, , Spain

Site Status

H. Universitario La Princesa Servicio de Neurología

Madrid, , Spain

Site Status

H. Ramón y Cajal Servicio de Neurología

Madrid, , Spain

Site Status

H. Virgen del Rocío Servicio de Neurología

Seville, , Spain

Site Status

Hospital Universitario La Fe Servicio de Neurología

Valencia, , Spain

Site Status

Hassleholms Sjukhus Stroke- och rehabiliteringsavdelningen 9

Hässleholm, , Sweden

Site Status

University Hospital Department of Neurology

Linköping, , Sweden

Site Status

Skaraborgs Sjukhus Skovde Strokenheten

Skövde, , Sweden

Site Status

Danderyds Sjukhus Medicinmottagningen

Stockholm, , Sweden

Site Status

Akademiska Sjukhuset Strokeavdelningen 85B

Uppsala, , Sweden

Site Status

Royal United Hospital Older People's Unit

Bath, , United Kingdom

Site Status

Queen Elizabeth University Hospital

Glasgow, , United Kingdom

Site Status

Northwick Park Hospital Neurology

Harrow, , United Kingdom

Site Status

Leicester Royal Infirmary Dpt of Neurology

Leicester, , United Kingdom

Site Status

St George's University Hospitals Stroke Research office

London, , United Kingdom

Site Status

Nottingham City Hospital

Nottingham, , United Kingdom

Site Status

Poole NHS Foundation Trust Stroke Unit

Poole, , United Kingdom

Site Status

Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital

Sheffield, , United Kingdom

Site Status

Royal Stoke University Hospital Stroke Team Office

Stoke-on-Trent, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia Belgium Brazil Canada Czechia France Germany Hungary Italy Netherlands Poland South Korea Spain Sweden United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Chabriat H, Bassetti CL, Marx U, Picarel-Blanchot F, Sors A, Gruget C, Saba B, Wattez M, Audoli ML, Hermann DM. Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study. Trials. 2020 Feb 3;21(1):136. doi: 10.1186/s13063-020-4072-2.

Reference Type BACKGROUND
PMID: 32014032 (View on PubMed)

Chabriat H, Bassetti CL, Marx U, Audoli-Inthavong ML, Sors A, Lambert E, Wattez M, Hermann DM; RESTORE BRAIN study investigators. Safety and efficacy of GABAA alpha5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2020 Mar;19(3):226-233. doi: 10.1016/S1474-4422(20)30004-1.

Reference Type RESULT
PMID: 32085836 (View on PubMed)

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: Study Protocol

View Document

Document Type: Individual Participant Data Set

View Document

Document Type: Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Document Type: Clinical Study Report

View Document

Document Type: Study-level clinical trial data

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-001005-16

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

UTN number: U1111-1180-8991

Identifier Type: OTHER

Identifier Source: secondary_id

CL2-44819-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.